Delivery Order SPE2DB24D2205-SPE2DB24FDZCN
Award Date
8/27/24
Potential Completion Date
8/28/24
Potential Value
$51K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $63,270.00 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The order is for the supply of 4,565,425,799 doses of the BOOSTRIX TDAP vaccine in 0.5mL syringes. The contract has an ultimate completion date of August 13, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to...
This is a $25,814.16 firm fixed price delivery order awarded to Amerisourcebergen Drug Corp, Corporate Office Division by the Defense Logistics Agency (DLA) for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The contract has an ultimate completion date of July 19, 2024. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical products and supplies to federal agencies, including the military. This contract is part of a larger Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $20,246.40 firm-fixed-price contract is for the supply of the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML product, with a completion date of August 14, 2024. Amerisourcebergen is a leading pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range of medical commodities, including medications, vaccines, and medical supplies, to...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $1,021.76 firm-fixed price contract is for the supply of 4,565,913,991 units of the BOOSTRIX TDAP vaccine syringe 0.5 mL. The contract has an ultimate completion date of September 25, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of essential medical commodities, including...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The $2,026.15 order is for the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, to be delivered by March 8, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies,...
This is a $3,026.56 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, a vaccine product. It does not have a set-aside designation. The contract has an ultimate completion date of September 12, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, and this award is part of...
The U.S. Defense Logistics Agency (DLA) awarded a $25,778 firm-fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of 4,564,306 units of the BOOSTRIX TDAP vaccine syringe (0.5 mL). This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
This is a $4,085.47 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide BOOSTRIX TDAP vaccine syringes. The contract has an ultimate completion date of July 25, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which enables the DLA to efficiently procure a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $1,265.40 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distributor AmerisourceBergen Corporation. This order is for the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML product and has an ultimate completion date of April 10, 2024. AmerisourceBergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025. This IDC serves as...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of BOOSTRIX TDAP vaccine syringes. The $1,064.40 firm-fixed-price delivery order has a completion date of June 6, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...